200244
Bayesian Change Point Models and Missing Data Analysis for Menstrual Diary Data at the Approach of Menopause
Monday, November 9, 2009: 8:30 AM
Xiaobi Huang
,
Department of Biostatistics, University of Michigan, Ann Arbor, MI
Siobán D. Harlow, PhD
,
Department of Epidemiology, University of Michigan, Ann Arbor, MI
Michael R. Elliott
,
Department of Biostatistics, School of Public Health, University of Michigan at Ann Arbor, Ann Arbor, MI
As women approach menopause, the patterns of their menstruation segment lengths change. In order to study when changes in menstrual length happen, we use Bayesian change point models to jointly model both the mean variability of the segment length. The model incorporates separate mean and variance change points for each woman and a hierarchical model to link them together, along with regression components to include predictors of menopausal onset such as age at menarche and parity. Data are from TREMIN, an ongoing 70-year old longitudinal study that has obtained menstrual calendar data of women throughout their life course. Our study cohort includes nearly 1000 women, many of whom have missingness due to hormone use, surgery, random missingness and loss of contact. We integrate multiple imputation in our Bayesian estimation procedure to deal with different forms of the missingness. Posterior predictive model checks are applied to evaluate the model fit.
Learning Objectives: Identify two change points as women approaching menopause.
Describe multiple imputation to handle different types of missing data.
Keywords: Reproductive Health, Menopause
Presenting author's disclosure statement:Qualified on the content I am responsible for because: Ph.D. Candidate in Biostatistics, University of Michigan 2006-Present
Research Assistant in Women's Menstrual and Reproductive History Study 01/2008-Present
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|